TPD & Induced Proximity Summit Leaderboard
  • Wednesday, July 1, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 246

Author

Pharma Journalist 8906 posts 0 comments

Developments in Gene Therapy for Ocular Diseases

Aug 25, 2022
SAE Media Group reports: The Ophthalmic Drugs Conference will be focusing on developments in Gene Therapy for Ocular Diseases The Ophthalmic drugs industry continues to expand year…
Read More...

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Aug 24, 2022
Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previously announced viral vector…
Read More...

Windtree Therapeutics Announces KL4 Surfactant and AEROSURF Global License Agreement

Aug 24, 2022
Windtree Therapeutics, Inc. announced it has entered into a global licensing agreement with Lee’s Pharmaceutical (HK) Limited, (Lee’s) and its affiliate Zhaoke Pharmaceutical (Hefei)…
Read More...

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome technology platform in…

Aug 24, 2022
Hovione and Zerion Pharma A/S (Zerion) announced an extension of their collaboration on Zerion's Dispersome technology into the nutraceutical/dietary supplements field. Many dietary…
Read More...

Lacerta and Prevail Sign Agreement to Develop Novel AAV Capsids for CNS Disorders

Aug 24, 2022
Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid…
Read More...

iECURE Receives FDA Rare Pediatric Disease Designation for GTP-506, an Investigational Gene Editing…

Aug 23, 2022
iECURE, a gene editing company focused on developing therapies that utilize mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with…
Read More...

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

Aug 23, 2022
Alcon and Aerie Pharmaceuticals announced the companies have entered into a definitive merger agreement through which Alcon will acquire Aerie. This transaction affirms Alcon’s…
Read More...

Thermo Fisher Scientific’s Largest Single-Use Technology Manufacturing Site Opens in Greater…

Aug 23, 2022
Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million,…
Read More...

Pfizer and BioNTech Submit Application to FDA for Emergency Use Authorization of Omicron…

Aug 23, 2022
Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of…
Read More...

Gilead Announces First Global Regulatory Approval of Sunlenca (Lenacapavir), the Only Twice-Yearly…

Aug 23, 2022
Gilead Sciences, Inc. announced that the European Commission (EC) has granted Marketing Authorization for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV…
Read More...
Prev Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Zymeworks to Acquire Theravance Biopharma in $929 Million Deal
  • EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia
  • Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal
  • AstraZeneca, YMCA Launch National Cancer Education Partnership
  • Antares, Novartis Partner on Cancer Drug Discovery

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.